Lorenzo Ferrando

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 26

Top Venues

PLoS genetics

International journal of molecular sciences

NPJ breast cancer

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

University of Genoa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Genoa Nov 01 2017

Italy

PhD :: Internal Medicine

Memorial Sloan Kettering Cancer Center Nov 21 2018 - Nov 20 2019

United States

Graduate Research Assistant :: Pathology

Publications

Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 19 (1) (2023)
Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 19 (1) (2023)
Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 19 (1) (2023)
Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 19 (1) (2023)
Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 19 (1) (2023)
Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 19 (1) (2023)
Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 19 (1) (2023)
Gabriella Cirmena, Lorenzo Ferrando, Francesco Ravera, Anna Garuti, Martina Dameri, Maurizio Gallo, Valentina Barbero, Fabio Ferrando, Lucia Del Mastro, Alessandro Garlaschi, Daniele Friedman, Piero Fregatti, Alberto Ballestrero, Francesco Ravera
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer. JCO precision oncology 6 (2022)
Lorenza Pastorino, Bruna Dalmasso, Eleonora Allavena, Irene Vanni, Filippo Ugolini, Gianna Baroni, Michela Croce, Antonio Guadagno, Francesco Cabiddu, Virginia Andreotti, William Bruno, Gabriele Zoppoli, Lorenzo Ferrando, Enrica Teresa Tanda, Francesco Spagnolo, Chiara Menin, Rosaria Gangemi, Daniela Massi, Paola Ghiorzo
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma. International journal of molecular sciences 23 (24) (2022)
Lorenza Pastorino, Bruna Dalmasso, Eleonora Allavena, Irene Vanni, Filippo Ugolini, Gianna Baroni, Michela Croce, Antonio Guadagno, Francesco Cabiddu, Virginia Andreotti, William Bruno, Gabriele Zoppoli, Lorenzo Ferrando, Enrica Teresa Tanda, Francesco Spagnolo, Chiara Menin, Rosaria Gangemi, Daniela Massi, Paola Ghiorzo
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma. International journal of molecular sciences 23 (24) (2022)
Lorenza Pastorino, Bruna Dalmasso, Eleonora Allavena, Irene Vanni, Filippo Ugolini, Gianna Baroni, Michela Croce, Antonio Guadagno, Francesco Cabiddu, Virginia Andreotti, William Bruno, Gabriele Zoppoli, Lorenzo Ferrando, Enrica Teresa Tanda, Francesco Spagnolo, Chiara Menin, Rosaria Gangemi, Daniela Massi, Paola Ghiorzo
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma. International journal of molecular sciences 23 (24) (2022)
Lorenza Pastorino, Bruna Dalmasso, Eleonora Allavena, Irene Vanni, Filippo Ugolini, Gianna Baroni, Michela Croce, Antonio Guadagno, Francesco Cabiddu, Virginia Andreotti, William Bruno, Gabriele Zoppoli, Lorenzo Ferrando, Enrica Teresa Tanda, Francesco Spagnolo, Chiara Menin, Rosaria Gangemi, Daniela Massi, Paola Ghiorzo
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma. International journal of molecular sciences 23 (24) (2022)
Edaise M Da Silva, Pier Selenica, Mahsa Vahdatinia, Fresia Pareja, Arnaud Da Cruz Paula, Lorenzo Ferrando, Andrea M Gazzo, Higinio Dopeso, Dara S Ross, Ariya Bakhteri, Nadeem Riaz, Sarat Chandarlapaty, Pedram Razavi, Larry Norton, Hannah Y Wen, Edi Brogi, Jorge S Reis-Filho, Hong Zhang, Jorge Sergio Reis-Filho
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer. NPJ breast cancer 7 (1) (2021)
Nina Radosevic-Robin, Pier Selenica, Yingjie Zhu, Helen H Won, Michael F Berger, Lorenzo Ferrando, Emiliano Cocco, Maud Privat, Flora Ponelle-Chachuat, Catherine Abrial, Jean-Marc Nabholtz, Frederique Penault-Llorca, Jorge Sergio Reis-Filho, Maurizio Scaltriti
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies. NPJ breast cancer 7 (1) (2021)
Edaise M Da Silva, Daniel J Fix, Ana Paula Martins Sebastiao, Pier Selenica, Lorenzo Ferrando, Sarah H Kim, Anthe Stylianou, Arnaud Da Cruz Paula, Fresia Pareja, Evan S Smith, Ahmet Zehir, Jason A Konner, Karen Cadoo, Jorge Sergio Reis-Filho, Nadeem R Abu-Rustum, Jennifer J Mueller, Jorge S Reis-Filho, Kay J Park
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (8) (2021)
Martina Dameri, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero, Francesco Ravera
Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer. International journal of molecular sciences 22 (13) (2021)
Irene Caffa, Vanessa Spagnolo, Claudio Vernieri, Francesca Valdemarin, Pamela Becherini, Min Wei, Sebastian Brandhorst, Chiara Zucal, Else Driehuis, Lorenzo Ferrando, Francesco Piacente, Alberto Tagliafico, Michele Cilli, Luca Mastracci, Valerio G Vellone, Silvano Piazza, Anna Laura Cremonini, Raffaella Gradaschi, Carolina Mantero, Mario Passalacqua, Alberto Ballestrero, Gabriele Zoppoli, Michele Cea, Annalisa Arrighi, Patrizio Odetti, Fiammetta Monacelli, Giulia Salvadori, Salvatore Cortellino, Hans Clevers, Filippo De Braud, Samir G Sukkar, Alessandro Provenzani, Valter Daniel Longo, Alessio Nencioni
Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature (2020)
Lorenzo Ferrando, Gabriella Cirmena, Anna Garuti, Stefano Scabini, Federica Grillo, Luca Mastracci, Edoardo Isnaldi, Ciro Marrone, Roberta Gonella, Roberto Murialdo, Roberto Fiocca, Emanuele Romairone, Alberto Ballestrero, Francesco Ravera
Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma. PloS one 15 (2) (2020)
Fresia Pareja, David N Brown, Ju Youn Lee, Arnaud Da Cruz Paula, Pier Selenica, Rui Bi, Felipe C Geyer, Andrea Gazzo, Edaise M da Silva, Mahsa Vahdatinia, Anthe A Stylianou, Lorenzo Ferrando, Hannah Y Wen, James B Hicks, Britta Weigelt, Jorge S Reis-Filho
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Guotai Xu, Sagar Chhangawala, Emiliano Cocco, Pedram Razavi, Yanyan Cai, Jordan E Otto, Lorenzo Ferrando, Pier Selenica, Erik Ladewig, Carmen Chan, Arnaud Da Cruz Paula, Matthew Witkin, Yuanming Cheng, Jane Park, Cristian Serna-Tamayo, HuiYong Zhao, Fan Wu, Mirna Sallaku, Xuan Qu, Alison Zhao, Clayton K Collings, Andrew R D'Avino, Komal Jhaveri, Richard P Koche, Ross L Levine, Jorge Sergio Reis-Filho, Cigall Kadoch, Maurizio Scaltriti, Christina S Leslie, Jose Baselga, Eneda Toska
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer. Nature genetics 52 (2) (2020)
Irene Caffa, Vanessa Spagnolo, Claudio Vernieri, Francesca Valdemarin, Pamela Becherini, Min Wei, Sebastian Brandhorst, Chiara Zucal, Else Driehuis, Lorenzo Ferrando, Francesco Piacente, Alberto Tagliafico, Michele Cilli, Luca Mastracci, Valerio G Vellone, Silvano Piazza, Anna Laura Cremonini, Raffaella Gradaschi, Carolina Mantero, Mario Passalacqua, Alberto Ballestrero, Gabriele Zoppoli, Michele Cea, Annalisa Arrighi, Patrizio Odetti, Fiammetta Monacelli, Giulia Salvadori, Salvatore Cortellino, Hans Clevers, Filippo De Braud, Samir G Sukkar, Alessandro Provenzani, Valter Daniel Longo, Alessio Nencioni
Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 583 (7817) (2020)
Sarah H Kim, Arnaud Da Cruz Paula, Thais Basili de Oliveira, Higinio Dopeso, Rui Bi, Fresia Pareja, Edaise M Da Silva, Rodrigo Gularte-Mérida, Zhen Sun, Sho Fujisawa, Caitlin G Smith, Lorenzo Ferrando, Ana Paula Martins Sebastião, Yonina Bykov, Anqi Li, Catarina Silveira, Charles W Ashley, Anthe Stylianou, Pier Selenica, Wesley R Samore, Achim A Jungbluth, Dmitriy Zamarin, Nadeem R Abu-Rustum, Kristian Helin, Robert A Soslow, Jorge Sergio Reis-Filho, Esther Oliva, Britta Weigelt
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary. Nature communications 11 (1) (2020)
Fresia Pareja, Lorenzo Ferrando, Simon S K Lee, Francisco Beca, Pier Selenica, David N Brown, Amir Farmanbar, Arnaud Da Cruz Paula, Mahsa Vahdatinia, Hong Zhang, Gabriele Zoppoli, Hannah Y Wen, Edi Brogi, Mark E Robson, Pedram Razavi, Sarat Chandarlapaty, Jorge S Reis-Filho, Jorge Sergio Reis-Filho
The genomic landscape of metastatic histologic special types of invasive breast cancer. NPJ breast cancer 6 (2020)
Arnaud Da Cruz Paula, Edaise M Da Silva, Sheila E Segura, Fresia Pareja, Rui Bi, Pier Selenica, Sarah H Kim, Lorenzo Ferrando, Mahsa Vahdatinia, Robert A Soslow, August Vidal, Sonia Gatius, Christopher G Przybycin, Nadeem R Abu-Rustum, Xavier Matias-Guiu, Brian P Rubin, Jorge Sergio Reis-Filho, Deborah F DeLair, Britta Weigelt
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (8) (2020)
Francisco Beca, Simon S K Lee, Fresia Pareja, Arnaud Da Cruz Paula, Pier Selenica, Lorenzo Ferrando, Rodrigo Gularte-Mérida, Hannah Y Wen, Hong Zhang, Elena Guerini-Rocco, Emad A Rakha, Britta Weigelt, Jorge Sergio Reis-Filho
Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast. Histopathology 75 (6) (2019)
Caterina Marchiò, Arnaud Da Cruz Paula, Rodrigo Gularte-Mérida, Thais Basili de Oliveira, Alissa Brandes, Edaise M da Silva, Catarina Silveira, Lorenzo Ferrando, Jasna Metovic, Francesca Maletta, Laura Annaratone, Fresia Pareja, Brian P Rubin, Aaron P Hoschar, Giovanni De Rosa, Stefano La Rosa, Massimo Bongiovanni, Bibianna Purgina, Simonetta Piana, Marco Volante, Britta Weigelt, Jorge S Reis-Filho, Mauro Papotti
PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (12) (2019)

Lorenzo Ferrando.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lorenzo Ferrando